Global Marine Pharmaceuticals Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Marine Pharmaceuticals Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
The drug obtained from marine organisms which are being conventionally used like shark and cod-liver oils, sodium alginate, agar-agar, chitin etc.
Marine organisms are potential source for drug discovery. Life has originated from the oceans that cover over 70% of the surface of earth and contain highly ecological, chemical and biological diversity starting from micro-organisms to vertebrates. This diversity has been the source of unique chemical compounds, which hold tremendous pharmaceutical potential.
Marine Pharmaceuticals report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Marine Pharmaceuticals market is projected to reach US$ 52570 million in 2034, increasing from US$ 29500 million in 2022, with the CAGR of 8.5% during the period of 2024 to 2034. Demand from Hospital & Clinic and Pharmacy are the major drivers for the industry.
Global Marine Pharmaceuticals key players include Seattle Genetics, Inc., DSM, Eisai Co, Takeda, BASF, Amway, etc. Global top six manufacturers hold a share about 10%.
North America is the largest market, with a share about 35%, followed by Europe and China, both have a share over 35 percent.
In terms of product, Health Supplement is the largest segment, with a share about 90%. And in terms of application, the largest application is Pharmacy, followed by Hospital & Clinic.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Marine Pharmaceuticals market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Seattle Genetics
DSM
Eisai Co
Takeda
BASF
Amway
Pfizer
Pelagia (EPAX)
Pharma Mar SA
Croda
GNC
GSK
TerSera Therapeutics
Nordic Naturals
Carlson Labs
Segment by Type
Drugs
Health Supplement
Hospital & Clinic
Pharmacy
Other
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Marine Pharmaceuticals market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Marine Pharmaceuticals, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Marine Pharmaceuticals industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Marine Pharmaceuticals in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Marine Pharmaceuticals introduction, etc. Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Marine Pharmaceuticals market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Marine organisms are potential source for drug discovery. Life has originated from the oceans that cover over 70% of the surface of earth and contain highly ecological, chemical and biological diversity starting from micro-organisms to vertebrates. This diversity has been the source of unique chemical compounds, which hold tremendous pharmaceutical potential.
Marine Pharmaceuticals report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Marine Pharmaceuticals market is projected to reach US$ 52570 million in 2034, increasing from US$ 29500 million in 2022, with the CAGR of 8.5% during the period of 2024 to 2034. Demand from Hospital & Clinic and Pharmacy are the major drivers for the industry.
Global Marine Pharmaceuticals key players include Seattle Genetics, Inc., DSM, Eisai Co, Takeda, BASF, Amway, etc. Global top six manufacturers hold a share about 10%.
North America is the largest market, with a share about 35%, followed by Europe and China, both have a share over 35 percent.
In terms of product, Health Supplement is the largest segment, with a share about 90%. And in terms of application, the largest application is Pharmacy, followed by Hospital & Clinic.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Marine Pharmaceuticals market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Seattle Genetics
DSM
Eisai Co
Takeda
BASF
Amway
Pfizer
Pelagia (EPAX)
Pharma Mar SA
Croda
GNC
GSK
TerSera Therapeutics
Nordic Naturals
Carlson Labs
Segment by Type
Drugs
Health Supplement
Segment by Application
Hospital & Clinic
Pharmacy
Other
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Marine Pharmaceuticals market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Marine Pharmaceuticals, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Marine Pharmaceuticals industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Marine Pharmaceuticals in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Marine Pharmaceuticals introduction, etc. Marine Pharmaceuticals Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Marine Pharmaceuticals market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.